rs3218673

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP2_StrongBP4BA1

This summary comes from the ClinGen Evidence Repository: The ATM c.2614C>T (p.Pro872Ser) variant has a GnomAD FAF 4.6% (AFR) exceeding ATM BA1 threshold of .5% (BA1). This variant has been observed in a homozygous or compound heterozygous state (presumed and/or confirmed) in multiple individuals without Ataxia-Telangiectasia (BP2_Strong, Clinical Diagnostic Laboratories). This variant is predicted tolerated by multiple protein in silico tools (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the HBOP Variant Curation Expert Panel. LINK:https://erepo.genome.network/evrepo/ui/classification/CA157083/MONDO:0016419/020

Frequency

Genomes: 𝑓 0.013 ( 53 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 39 hom. )

Consequence

ATM
NM_000051.4 missense

Scores

17

Clinical Significance

Benign reviewed by expert panel B:29O:1

Conservation

PhyloP100: 1.04

Publications

37 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BP4
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.2614C>Tp.Pro872Ser
missense
Exon 17 of 63NP_000042.3
ATM
NM_001351834.2
c.2614C>Tp.Pro872Ser
missense
Exon 18 of 64NP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.2614C>Tp.Pro872Ser
missense
Exon 17 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.2614C>Tp.Pro872Ser
missense
Exon 18 of 64ENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.2614C>Tp.Pro872Ser
missense
Exon 17 of 30ENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.0128
AC:
1946
AN:
152006
Hom.:
53
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0437
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00648
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00960
GnomAD2 exomes
AF:
0.00353
AC:
888
AN:
251426
AF XY:
0.00251
show subpopulations
Gnomad AFR exome
AF:
0.0478
Gnomad AMR exome
AF:
0.00202
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000185
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00133
AC:
1943
AN:
1461778
Hom.:
39
Cov.:
31
AF XY:
0.00118
AC XY:
861
AN XY:
727190
show subpopulations
African (AFR)
AF:
0.0450
AC:
1506
AN:
33470
American (AMR)
AF:
0.00268
AC:
120
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53404
Middle Eastern (MID)
AF:
0.00277
AC:
16
AN:
5768
European-Non Finnish (NFE)
AF:
0.000108
AC:
120
AN:
1111948
Other (OTH)
AF:
0.00290
AC:
175
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
96
192
289
385
481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0128
AC:
1953
AN:
152126
Hom.:
53
Cov.:
32
AF XY:
0.0117
AC XY:
873
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.0438
AC:
1817
AN:
41500
American (AMR)
AF:
0.00648
AC:
99
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
67980
Other (OTH)
AF:
0.00950
AC:
20
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
90
180
269
359
449
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00592
Hom.:
40
Bravo
AF:
0.0152
ESP6500AA
AF:
0.0470
AC:
207
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00463
AC:
562
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
9
not specified (10)
-
-
6
not provided (6)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
Ataxia-telangiectasia syndrome (3)
-
-
2
Familial cancer of breast (2)
-
-
1
Ataxia-telangiectasia syndrome;C0346153:Familial cancer of breast (1)
-
-
1
ATM-related cancer predisposition (1)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
9.8
DANN
Benign
0.56
DEOGEN2
Benign
0.048
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.091
N
LIST_S2
Benign
0.69
T
MetaRNN
Benign
0.0022
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.2
N
PhyloP100
1.0
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.55
N
REVEL
Benign
0.12
Sift
Benign
1.0
T
Sift4G
Benign
0.52
T
Polyphen
0.0
B
Vest4
0.052
MVP
0.64
MPC
0.12
ClinPred
0.0034
T
GERP RS
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.018
gMVP
0.11
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3218673; hg19: chr11-108138045; COSMIC: COSV53733521; API